-
Schwartz Dissertation: Better Drug Response Metrics
2026-09-30
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth arrest and cell death are related but non-equivalent components of anticancer drug response. The framework supports better experimental interpretation by pairing response magnitude with timing and by avoiding conclusions based on a single viability endpoint.
-
Sodium Phosphate Dibasic for Reliable Assays
2026-09-30
Sodium phosphate dibasic provides a practical aqueous route to tighter pH control in protein, enzyme, cell-based, and molecular biology workflows. This guide connects Na2HPO4 buffer preparation with stability-aware nucleic acid nanoparticle assays while separating established handling guidance from application-specific validation.
-
Bafilomycin C1 in High-Content Phenotype Design
2026-09-29
Bafilomycin C1 is a vacuolar H+-ATPases inhibitor that can turn lysosomal acidification into an interpretable perturbation in high-content assays. This guide connects V-ATPase biology with deep-learning phenotypic screening while emphasizing controls that distinguish autophagy flux, cytotoxicity, and cardiomyocyte-specific signal.
-
MK 0893: Glucagon Receptor Antagonist Workflows
2026-09-29
MK 0893 enables a practical bridge from nanomolar GCGR pharmacology to cell-based cAMP assays and glucose-excursion studies in humanized receptor models. This guide emphasizes assay setup, structure-informed validation, selectivity controls, and troubleshooting for type 2 diabetes research.
-
Fluoxetine HCl Workflows for Neuroscience Research
2026-09-28
Connect Fluoxetine HCl serotonin-transporter pharmacology to 5-HT2C assays, plasticity endpoints, and carefully controlled reward-behavior studies. A developmental SSRI-exposure model highlights why motivation, reward liking, and learning should be measured separately—and why cell-assay results do not by themselves predict behavioral outcomes.
-
DiscoveryProbe™ Stem Cell Library: Pathway to Phenotype
2026-09-27
DiscoveryProbe Stem Cell Compound Library Plus supports stem cell pathway profiling across signaling systems that shape proliferation, self-renewal, and differentiation. This article explains how to turn pathway perturbations into interpretable phenotypic evidence—and what a cross-species screening study can and cannot establish.
-
Anisomycin: JNK Agonist Workflows for Cell Research
2026-09-26
Use Anisomycin to probe JNK-linked stress signaling and apoptosis with a workflow that separates rapid pathway engagement from later cell-death outcomes. Practical dose-and-time pilots, controls, and clear limits on extrapolation help distinguish a useful JNK perturbation from an overinterpreted phenotype.
-
Native Protein Gel Electrophoresis with K4142
2026-09-26
K4142 supports native PAGE workflows for acidic proteins while preserving the conditions needed to investigate protein assemblies and activity. This practical guide connects the kit to cancer-biology research, with clear assay boundaries, pilot parameters, and troubleshooting steps.
-
4-MUG Assays for Gaucher Disease Research
2026-09-25
Use 4-Methylumbelliferyl-β-D-Glucopyranoside to quantify glycosidase activity in lysosomal and Gaucher disease models, with practical guidance for controls, calibration, and fluorescence readout. The workflow connects enzyme measurements to emerging GBA1 mRNA research without implying that the cited study used this specific substrate.
-
(±)-Blebbistatin for Spatial Cell Mechanics Assays
2026-09-25
Use (±)-Blebbistatin to test how non-muscle myosin II-dependent force contributes to cell migration, adhesion, and shape—while keeping the perturbation spatially registered to the phenotype. A practical workflow pairs dose titration and washout with multimodal imaging, borrowing mapping principles from cardiac research without confusing the two experimental domains.
-
Paclitaxel (Taxol): Mitotic Stress and Tissue Repair
2026-09-24
Paclitaxel (Taxol) is a powerful tool for probing microtubule dynamics and mitotic stress, but tumor-cell assays cannot answer every question about chemotherapy-associated tissue injury. This article connects its research use to a distinct hydrogel–nanovesicle wound-healing study and shows how to keep those experimental questions separate.
-
Alosetron and Intestinal Polarity Research
2026-09-24
A translational framework for using Alosetron to interrogate 5-HT3 receptor pharmacology alongside CDC42–YAP–mTOR research—without assuming these pathways are already mechanistically linked.
-
Zosuquidar: A Transporter Lens on PROTAC Resistance
2026-09-23
Zosuquidar (LY335979) is more than a conventional multidrug-resistance probe: it can reveal when ABCB1-mediated drug export, rather than target mutation, limits modern degrader activity. This article translates recent resistance findings into practical assay and experimental-design decisions.
-
Angiotensin Peptides Enhance SARS-CoV-2 Spike Binding
2026-09-23
A 2025 study found that Angiotensin II and selected naturally occurring derivatives increase biochemical binding between the SARS-CoV-2 spike protein and host receptors, with the strongest effects associated with specific peptide truncations and tyrosine modifications. The results identify angiotensin-peptide structure as a potential determinant of receptor engagement, while remaining an early biochemical observation rather than clinical evidence of altered viral infection.
-
Telmisartan for Reliable Cell Assays
2026-09-22
Learn how Telmisartan (SKU A8531) can improve experimental control in cell viability, proliferation, cytotoxicity, and cardiac hypertrophy workflows. This scenario-based guide covers mechanism, DMSO formulation, protocol design, data interpretation, and practical vendor selection.